Heterogeneity of EGFR Aberrations and Correlation with Histological Structures: Analyses of Therapy-Naive Isogenic Lung Cancer Lesions with EGFR Mutation.

作者: Kenichi Suda , Isao Murakami , Hui Yu , Kim Ellison , Masaki Shimoji

DOI: 10.1016/J.JTHO.2016.05.017

关键词:

摘要: Abstract Introduction EGFR gene somatic mutation is reportedly homogeneous. However, there are few data regarding the heterogeneity of expression mutant protein and copy number, especially in extrathoracic lesions. These types may enhance our understanding the biology -mutated lung cancer and our heterogeneous response patterns to TKIs. Methods An 81-year-old never-smoking female with adenocarcinoma could not receive any systemic therapy because her poor performance status. After death, 15 tumor specimens from different sites were obtained by autopsy. Expression  gene numbers assessed by immunohistochemical analysis silver situ hybridization, respectively. Heterogeneity these aberrations was compared between metastatic (distant versus lymph node) or histological structures (micropapillary nonmicropapillary). Results All lesions showed positive staining for protein, except 40% papillary component one pulmonary metastases (weak below the 1+ threshold). mutant-specific evaluated H-score, was significantly higher micropapillary components than nonmicropapillary (Mann-Whitney U test, p  = 0.014). number quite but correlated structure form. similar each lesion. Conclusion indicate that do change as a consequence progression. This also justifies using biopsy surrogate primary tumors.

参考文章(19)
Kenichi Suda, Tetsuya Mitsudomi, Role of EGFR mutations in lung cancers: prognosis and tumor chemosensitivity Archives of Toxicology. ,vol. 89, pp. 1227- 1240 ,(2015) , 10.1007/S00204-015-1524-7
Koichi Azuma, Isamu Okamoto, Akihiko Kawahara, Tomoki Taira, Kazutaka Nakashima, Satoshi Hattori, Takashi Kinoshita, Masayuki Takeda, Kazuhiko Nakagawa, Shinzo Takamori, Michihiko Kuwano, Mayumi Ono, Masayoshi Kage, Association of the expression of mutant epidermal growth factor receptor protein as determined with mutation-specific antibodies in non-small cell lung cancer with progression-free survival after gefitinib treatment. Journal of Thoracic Oncology. ,vol. 7, pp. 122- 127 ,(2012) , 10.1097/JTO.0B013E31822EEBA2
Federico Cappuzzo, Fred R. Hirsch, Elisa Rossi, Stefania Bartolini, Giovanni L. Ceresoli, Lynne Bemis, Jerry Haney, Samir Witta, Kathleen Danenberg, Irene Domenichini, Vienna Ludovini, Elisabetta Magrini, Vanesa Gregorc, Claudio Doglioni, Angelo Sidoni, Maurizio Tonato, Wilbur A. Franklin, Lucio Crino, Paul A. Bunn, Marileila Varella-Garcia, Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer Journal of the National Cancer Institute. ,vol. 97, pp. 643- 655 ,(2005) , 10.1093/JNCI/DJI112
Keisuke Tabara, Rina Kanda, Kahori Sonoda, Takuya Kubo, Yuichi Murakami, Akihiko Kawahara, Koichi Azuma, Hideyuki Abe, Masayoshi Kage, Aki Yoshinaga, Tomoko Tahira, Kenshi Hayashi, Tokuzo Arao, Kazuto Nishio, Rafael Rosell, Michihiko Kuwano, Mayumi Ono, Loss of Activating EGFR Mutant Gene Contributes to Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer Cells PLoS ONE. ,vol. 7, pp. e41017- ,(2012) , 10.1371/JOURNAL.PONE.0041017
Lorenzo Daniele, Paola Cassoni, Elisa Bacillo, Susanna Cappia, Luisella Righi, Marco Volante, Fabrizio Tondat, Giorgio Inghirami, Anna Sapino, Giorgio V. Scagliotti, Mauro Papotti, Silvia Novello, Epidermal Growth Factor Receptor Gene in Primary Tumor and Metastatic Sites from Non-small Cell Lung Cancer Journal of Thoracic Oncology. ,vol. 4, pp. 684- 688 ,(2009) , 10.1097/JTO.0B013E3181A52359
Koh Furugaki, Toshiki Iwai, Yoichiro Moriya, Naoki Harada, Kaori Fujimoto-Ouchi, Loss of an EGFR-amplified chromosome 7 as a novel mechanism of acquired resistance to EGFR-TKIs in EGFR-mutated NSCLC cells Lung Cancer. ,vol. 83, pp. 44- 50 ,(2014) , 10.1016/J.LUNGCAN.2013.10.003
Dalia Ercan, Kreshnik Zejnullahu, Kimio Yonesaka, Yun Xiao, Marzia Capelletti, Andrew Rogers, Eugene Lifshits, Alison Brown, Charles Lee, James G Christensen, David J Kwiatkowski, Jeffrey A Engelman, Pasi A Jänne, Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor Oncogene. ,vol. 29, pp. 2346- 2356 ,(2010) , 10.1038/ONC.2009.526
William D Travis, Elisabeth Brambilla, Masayuki Noguchi, Andrew G Nicholson, Kim R Geisinger, Yasushi Yatabe, David G Beer, Charles A Powell, Gregory J Riely, Paul E Van Schil, Kavita Garg, John HM Austin, Hisao Asamura, Valerie W Rusch, Fred R Hirsch, Giorgio Scagliotti, Tetsuya Mitsudomi, Rudolf M Huber, Yuichi Ishikawa, James Jett, Montserrat Sanchez-Cespedes, Jean-Paul Sculier, Takashi Takahashi, Masahiro Tsuboi, Johan Vansteenkiste, Ignacio Wistuba, Pan-Chyr Yang, Denise Aberle, Christian Brambilla, Douglas Flieder, Wilbur Franklin, Adi Gazdar, Michael Gould, Philip Hasleton, Douglas Henderson, Bruce Johnson, David Johnson, Keith Kerr, Keiko Kuriyama, Jin Soo Lee, Vincent A Miller, Iver Petersen, Victor Roggli, Rafael Rosell, Nagahiro Saijo, Erik Thunnissen, Ming Tsao, David Yankelewitz, None, International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma Journal of Thoracic Oncology. ,vol. 6, pp. 244- 285 ,(2011) , 10.1097/JTO.0B013E318206A221
Shinji Sumiyoshi, Akihiko Yoshizawa, Makoto Sonobe, Masashi Kobayashi, Masakazu Fujimoto, Tatsuaki Tsuruyama, Hiroshi Date, Hironori Haga, Pulmonary adenocarcinomas with micropapillary component significantly correlate with recurrence, but can be well controlled with EGFR tyrosine kinase inhibitors in the early stages Lung Cancer. ,vol. 81, pp. 53- 59 ,(2013) , 10.1016/J.LUNGCAN.2013.04.003
Caroline Mariano, Ian Bosdet, Aly Karsan, Diana Ionescu, Nevin Murray, Janessa J. Laskin, Yongliang Zhai, Barbara Melosky, Sophie Sun, Cheryl Ho, A population-based review of the feasibility of platinum-based combination chemotherapy after tyrosine kinase inhibition in EGFR mutation positive non-small cell lung cancer patients with advanced disease. Lung Cancer. ,vol. 83, pp. 73- 77 ,(2014) , 10.1016/J.LUNGCAN.2013.10.007